688163 赛伦生物
已收盘 12-29 15:00:00
资讯
新帖
简况
每周股票复盘：赛伦生物（688163）变更签字注册会计师
证券之星 · 12-28 05:17
每周股票复盘：赛伦生物（688163）变更签字注册会计师
赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%
证券之星 · 12-25
赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%
【私募调研记录】寿宁投资调研赛伦生物
证券之星 · 12-01
【私募调研记录】寿宁投资调研赛伦生物
赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与
证券之星 · 11-28
赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与
每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会
证券之星 · 11-09
每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会
赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%
证券之星 · 11-03
赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%
赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长
证券之星 · 10-29
赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长
股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%
证券之星 · 10-28
股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%
赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%
智通财经 · 10-27
赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%
每周股票复盘：赛伦生物（688163）拟每股派现0.12元（含税）
证券之星 · 09-21
每周股票复盘：赛伦生物（688163）拟每股派现0.12元（含税）
赛伦生物（688163）披露2025年半年度权益分派实施公告，9月19日股价上涨0.08%
证券之星 · 09-19
赛伦生物（688163）披露2025年半年度权益分派实施公告，9月19日股价上涨0.08%
赛伦生物（688163）6384.8万股限售股将于9月11日解禁，占总股本59%
证券之星 · 09-11
赛伦生物（688163）6384.8万股限售股将于9月11日解禁，占总股本59%
下周A股解禁市值逾960亿元
格隆汇 · 09-06
下周A股解禁市值逾960亿元
每周股票复盘：赛伦生物（688163）2025年中报扣非净利增25.08%
证券之星 · 08-31
每周股票复盘：赛伦生物（688163）2025年中报扣非净利增25.08%
赛伦生物（688163）2025年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-27
赛伦生物（688163）2025年中报简析：营收净利润同比双双增长，应收账款上升
赛伦生物收盘上涨4.15%，滚动市盈率64.10倍，总市值28.82亿元
金融界 · 08-26
赛伦生物收盘上涨4.15%，滚动市盈率64.10倍，总市值28.82亿元
赛伦生物(688163)6月30日股东户数0.77万户，较上期增加9.39%
证券之星 · 08-25
赛伦生物(688163)6月30日股东户数0.77万户，较上期增加9.39%
赛伦生物(688163.SH)发布半年度业绩，归母净利润3298万元，同比增长2.07%
智通财经 · 08-25
赛伦生物(688163.SH)发布半年度业绩，归母净利润3298万元，同比增长2.07%
赛伦生物：抗狂犬病血清已挂网销售
格隆汇 · 08-25
赛伦生物：抗狂犬病血清已挂网销售
每周股票复盘：赛伦生物（688163）召开2025年第一次临时股东大会，两项议案高票通过
证券之星 · 08-17
每周股票复盘：赛伦生物（688163）召开2025年第一次临时股东大会，两项议案高票通过
加载更多
公司概况
公司名称：
上海赛伦生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-11
主营业务：
上海赛伦生物技术股份有限公司的主营业务是研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物以及快速诊断产品。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。
发行价格：
33.03
{"stockData":{"symbol":"688163","market":"SH","secType":"STK","nameCN":"赛伦生物","latestPrice":21.7,"timestamp":1766991600000,"preClose":21.69,"halted":0,"volume":548247,"delay":0,"changeRate":0.0005,"floatShares":108000000,"shares":108000000,"eps":0.421,"marketStatus":"已收盘","change":0.01,"latestTime":"12-29 15:00:00","open":21.9,"high":21.9,"low":21.5,"amount":11865900,"amplitude":0.0184,"askPrice":21.7,"askSize":131,"bidPrice":21.69,"bidSize":30,"shortable":0,"etf":0,"ttmEps":0.421,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767058200000},"marketStatusCode":5,"adr":0,"adjPreClose":21.69,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766971800000,1766979000000],[1766984400000,1766991600000]],"highLimit":23.86,"lowLimit":19.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108220000,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":51.543943,"roe":"5.71%","epsLYR":0.41,"committee":-0.390029,"marketValue":2348000000,"turnoverRate":0.0051,"status":0,"afterMarket":{"amount":0,"volume":0,"close":21.7,"buyVolume":0,"sellVolume":0,"time":1766993637558,"indexStatus":"已收盘 12-29 15:30:00","preClose":21.69},"floatMarketCap":2348000000},"requestUrl":"/m/hq/s/688163","defaultTab":"news","newsList":[{"id":"2594906247","title":"每周股票复盘：赛伦生物（688163）变更签字注册会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2594906247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594906247?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:17","pubTimestamp":1766870230,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，赛伦生物报收于21.69元，较上周的22.24元下跌2.47%。本周，赛伦生物12月22日盘中最高价报22.41元。赛伦生物当前最新总市值23.47亿元，在生物制品板块市值排名51/51，在两市A股市值排名4928/5178。本周关注点公司公告汇总：赛伦生物因内部工作调整，原签字注册会计师金园变更为陈俞宜。陈俞宜自2021年起为注册会计师，2024年开始为公司提供审计服务，近三年无执业处罚记录，具备独立性。本次变更不影响公司2025年度审计工作的正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2594923067","title":"赛伦生物（688163）披露关于变更签字注册会计师的公告，12月25日股价上涨0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594923067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594923067?lang=zh_cn&edition=full","pubTime":"2025-12-25 23:07","pubTimestamp":1766675239,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，赛伦生物报收于22.15元，较前一交易日上涨0.41%，最新总市值为23.97亿元。近日，赛伦生物发布公告称，因天职国际会计师事务所内部工作调整，原签字注册会计师金园变更为陈俞宜，项目合伙人仍为郭海龙，项目质量复核人为张磊。陈俞宜自2021年起为注册会计师，2024年开始为公司提供审计服务，近三年无执业处罚记录，具备独立性。本次变更不影响公司2025年度审计工作的正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2588571934","title":"【私募调研记录】寿宁投资调研赛伦生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2588571934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588571934?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:01","pubTimestamp":1764547268,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月28日披露的机构调研信息，知名私募寿宁投资近期对1家上市公司进行了调研，相关名单如下：1）赛伦生物 调研纪要：公司除抗蛇毒血清外，还拥有马破伤风免疫球蛋白和抗狂犬病血清产品，并布局新型抗体、重组蛋白等技术平台，研发广谱抗蛇毒抗体等新药。募投项目扩建生产线位于上海青浦厂区，预计2026年建成，将提升产能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025120100000215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2586789762","title":"赛伦生物：11月14日进行路演，众合旭科技、JadeValue等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2586789762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586789762?lang=zh_cn&edition=full","pubTime":"2025-11-28 19:31","pubTimestamp":1764329507,"startTime":"0","endTime":"0","summary":"除抗蛇毒血清之外，公司已上市产品还包括用于预防与治疗破伤风的马破伤风免疫球蛋白和用于狂犬病预防的抗狂犬病血清。在抗蛇毒血清的国际市场方面，全球各个国家和地区的主要蛇种各不相同，需要结合各国的毒蛇分布种类和抗血清市场等具体情况来综合考虑。截至目前，公司没有调整抗蛇毒血清产品价格的计划。抗蛇毒血清产品有效期为3年。蛇毒中毒系基于毒素成分对生物体的特异性破坏。截至目前，抗血清仍然是治疗蛇伤的唯一特效药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800032717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2582646658","title":"每周股票复盘：赛伦生物（688163）将参加2025年11月13日业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582646658","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582646658?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:02","pubTimestamp":1762635739,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，赛伦生物报收于24.08元，较上周的24.38元下跌1.23%。本周，赛伦生物11月3日盘中最高价报24.51元。本周关注点公司公告汇总：赛伦生物将于2025年11月13日参加上海辖区上市公司三季报集体业绩说明会。业绩披露要点：公司已于2025年10月28日披露2025年第三季度报告。公司公告汇总：投资者可于2025年11月6日至11月12日16:00前通过上证路演中心或公司邮箱提前提问。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2580293582","title":"赛伦生物（688163）披露参加2025年上海辖区上市公司三季报集体业绩说明会的公告，11月03日股价下跌0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580293582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580293582?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:33","pubTimestamp":1762162422,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，赛伦生物报收于24.36元，较前一交易日下跌0.08%，最新总市值为26.36亿元。近日，赛伦生物发布关于参加2025年上海辖区上市公司三季报集体业绩说明会的公告。投资者可于2025年11月6日至11月12日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱dmb@serum-china.com进行提问。说明会结束后，投资者可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300024309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2579915522","title":"赛伦生物（688163）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2579915522","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579915522?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:17","pubTimestamp":1761689848,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期赛伦生物发布2025年三季报。根据财报显示，赛伦生物营收净利润同比双双增长。截至本报告期末，公司营业总收入1.75亿元，同比上升1.07%，归母净利润6421.07万元，同比上升2.01%。按单季度数据看，第三季度营业总收入7431.92万元，同比下降1.22%，第三季度归母净利润3123.39万元，同比上升1.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"gpt_icon":0},{"id":"2578674344","title":"股市必读：赛伦生物三季报 - 第三季度单季净利润同比增长1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578674344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578674344?lang=zh_cn&edition=full","pubTime":"2025-10-28 05:54","pubTimestamp":1761602061,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，赛伦生物报收于23.22元，下跌0.13%，换手率0.75%，成交量8146.0手，成交额1892.52万元。来自股本股东变化：截至2025年9月30日，赛伦生物股东户数较6月30日减少14.1%，户均持股数量升至1.63万股。来自业绩披露要点：2025年前三季度赛伦生物归母净利润同比增长2.01%，扣非净利润同比增长12.15%。2025年第三季度单季度主营收入7431.92万元，同比下降1.22%；单季度归母净利润3123.39万元，同比上升1.94%；单季度扣非净利润2790.86万元，同比上升1.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800006001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"gpt_icon":0},{"id":"2578614415","title":"赛伦生物(688163.SH)发布前三季度业绩，归母净利润6421万元，同比增长2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578614415","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578614415?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:18","pubTimestamp":1761560322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)披露2025年第三季度报告，公司前三季度实现营收1.75亿元，同比增长1.07%;归母净利润6421万元，同比增长2.01%;扣非净利润5644万元，同比增长12.15%;基本每股收益0.59元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163"],"gpt_icon":0},{"id":"2569246686","title":"每周股票复盘：赛伦生物（688163）拟每股派现0.12元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246686?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:12","pubTimestamp":1758399135,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，赛伦生物报收于23.79元，较上周的24.61元下跌3.33%。本周，赛伦生物9月17日盘中最高价报24.75元。本周关注点公司公告汇总：赛伦生物拟每股派发现金红利0.12元（含税），股权登记日为2025年9月25日。本次利润分配以总股本108,220,000股为基数，每股派发现金红利0.12元（含税），合计派发12,986,400.00元。分派对象为股权登记日在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2568261986","title":"赛伦生物（688163）披露2025年半年度权益分派实施公告，9月19日股价上涨0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568261986","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568261986?lang=zh_cn&edition=full","pubTime":"2025-09-19 22:35","pubTimestamp":1758292522,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，赛伦生物报收于23.79元，较前一交易日上涨0.08%，最新总市值为25.75亿元。该股当日开盘23.71元，最高23.99元，最低23.33元，成交额达2810.25万元，换手率为1.1%。近日，赛伦生物发布《2025年半年度权益分派实施公告》。股权登记日为2025年9月25日，除权（息）日与现金红利发放日均为2025年9月26日。分派对象为股权登记日在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900037407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2566352529","title":"赛伦生物（688163）6384.8万股限售股将于9月11日解禁，占总股本59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566352529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566352529?lang=zh_cn&edition=full","pubTime":"2025-09-11 08:05","pubTimestamp":1757549107,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，赛伦生物于9月11日将有6384.8万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本59.0%。本次解禁后，公司已无限售股份。赛伦生物主营业务：研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100005787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2565590771","title":"下周A股解禁市值逾960亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565590771","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565590771?lang=zh_cn&edition=full","pubTime":"2025-09-06 12:05","pubTimestamp":1757131546,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688187","BK0239","688114","688163","600995","BK0082","BK1565","BK1116","159982","301222","BK0271","BK0279","399300","03898","BK0224","BK0251","BK1171","BK0164","IE0032431581.USD"],"gpt_icon":0},{"id":"2563832057","title":"每周股票复盘：赛伦生物（688163）2025年中报扣非净利增25.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563832057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563832057?lang=zh_cn&edition=full","pubTime":"2025-08-31 15:29","pubTimestamp":1756625348,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，赛伦生物报收于24.61元，较上周的25.23元下跌2.46%。本周，赛伦生物8月26日盘中最高价报28.93元，股价触及近一年最高点。股本股东变化股东户数变动截至2025年6月30日，赛伦生物股东户数为7724.0户，较3月31日增加663.0户，增幅9.39%。业绩披露要点财务报告赛伦生物2025年中报显示，主营收入1.01亿元，同比上升2.82%；归母净利润3297.67万元，同比上升2.07%；扣非净利润2852.71万元，同比上升25.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100005076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2562687987","title":"赛伦生物（688163）2025年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2562687987","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562687987?lang=zh_cn&edition=full","pubTime":"2025-08-27 06:13","pubTimestamp":1756246428,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期赛伦生物发布2025年中报。截至本报告期末，公司营业总收入1.01亿元，同比上升2.82%，归母净利润3297.67万元，同比上升2.07%。本报告期赛伦生物应收账款上升，应收账款同比增幅达65.74%。截至2025年8月20日，本期期末应收账款的回款已过半。合同负债变动幅度为69.15%,原因:报告期末依据销售合同计提销售折让增加。筹资活动产生的现金流量净额变动幅度为0.0%,原因:本期分配现金股利与上期金额一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700008188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163"],"gpt_icon":0},{"id":"2562733180","title":"赛伦生物收盘上涨4.15%，滚动市盈率64.10倍，总市值28.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562733180","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562733180?lang=zh_cn&edition=full","pubTime":"2025-08-26 19:38","pubTimestamp":1756208333,"startTime":"0","endTime":"0","summary":"8月26日，赛伦生物今日收盘26.63元，上涨4.15%，滚动市盈率PE达到64.10倍，创17天以来新低，总市值28.82亿元。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均74.75倍，行业中值45.52倍，赛伦生物排名第57位。股东方面，截至2025年6月30日，赛伦生物股东户数7724户，较上次增加663户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年半年报，公司实现营业收入1.01亿元，同比2.82%；净利润3297.67万元，同比2.07%，销售毛利率77.34%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26193852710373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2562212727","title":"赛伦生物(688163)6月30日股东户数0.77万户，较上期增加9.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562212727","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562212727?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:23","pubTimestamp":1756113789,"startTime":"0","endTime":"0","summary":"证券之星消息，近日赛伦生物披露，截至2025年6月30日公司股东户数为7724.0户，较3月31日增加663.0户，增幅为9.39%。在生物制品行业个股中，赛伦生物股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.49万户。从股价来看，2025年3月31日至2025年6月30日，赛伦生物区间涨幅为14.32%，在此期间股东户数增加663.0户，增幅为9.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500023685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688163","BK0239"],"gpt_icon":0},{"id":"2562212874","title":"赛伦生物(688163.SH)发布半年度业绩，归母净利润3298万元，同比增长2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562212874","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562212874?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:06","pubTimestamp":1756112813,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛伦生物(688163.SH)披露2025年半年度报告，报告期公司实现营收1.01亿元，同比增长2.82%;归母净利润3298万元，同比增长2.07%;扣非净利润2853万元，同比增长25.08%;基本每股收益0.30元。公司拟向全体股东每10股派发现金红利1.20元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688163"],"gpt_icon":0},{"id":"2562211657","title":"赛伦生物：抗狂犬病血清已挂网销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2562211657","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562211657?lang=zh_cn&edition=full","pubTime":"2025-08-25 16:22","pubTimestamp":1756110120,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688163"],"gpt_icon":0},{"id":"2560492613","title":"每周股票复盘：赛伦生物（688163）召开2025年第一次临时股东大会，两项议案高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2560492613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560492613?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:18","pubTimestamp":1755382697,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，赛伦生物报收于26.15元，较上周的25.23元上涨3.65%。本周，赛伦生物8月15日盘中最高价报26.63元。赛伦生物当前最新总市值28.3亿元，在生物制品板块市值排名48/50，在两市A股市值排名4609/5152。本周关注点赛伦生物召开2025年第一次临时股东大会，两项议案分别以98.8880%和98.9419%的同意率通过公司公告汇总赛伦生物2025年第一次临时股东大会于2025年8月11日召开，会议由公司董事会召集，董事长范志和主持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688163"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767033957993,"stockEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.073},{"period":"3month","weight":-0.0726},{"period":"6month","weight":0.089},{"period":"1year","weight":0.2272},{"period":"ytd","weight":0.2551}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1478},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.183}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海赛伦生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6635人(较上一季度减少14.10%)","perCapita":"16310股","listingDate":"2022-03-11","address":"上海市青浦区华青路1288号","registeredCapital":"10822万元","survey":" 上海赛伦生物技术股份有限公司的主营业务是研究、开发、生产及销售针对生物毒素及生物安全领域的预防和治疗药物以及快速诊断产品。公司的主要产品是抗蝮蛇毒血清、抗五步蛇毒血清、抗眼镜蛇毒血清、抗银环蛇毒血清、马破伤风免疫球蛋白(F(ab')2)、抗狂犬病血清。","listedPrice":33.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛伦生物,688163,赛伦生物股票,赛伦生物股票老虎,赛伦生物股票老虎国际,赛伦生物行情,赛伦生物股票行情,赛伦生物股价,赛伦生物股市,赛伦生物股票价格,赛伦生物股票交易,赛伦生物股票购买,赛伦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛伦生物(688163)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛伦生物(688163)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}